DK76191D0 - Filamentoest haemagglutinin fra b.pertussis - Google Patents

Filamentoest haemagglutinin fra b.pertussis

Info

Publication number
DK76191D0
DK76191D0 DK91761A DK76191A DK76191D0 DK 76191 D0 DK76191 D0 DK 76191D0 DK 91761 A DK91761 A DK 91761A DK 76191 A DK76191 A DK 76191A DK 76191 D0 DK76191 D0 DK 76191D0
Authority
DK
Denmark
Prior art keywords
pertussis
therapy
filamentoest
haemagglutinin
filamentous hemagglutinin
Prior art date
Application number
DK91761A
Other languages
English (en)
Other versions
DK76191A (da
Inventor
David A Relman
Mario Domenighini
Rino Rappuoli
Stanley Falkow
Original Assignee
Univ Leland Stanford Junior
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Sclavo Spa filed Critical Univ Leland Stanford Junior
Publication of DK76191D0 publication Critical patent/DK76191D0/da
Publication of DK76191A publication Critical patent/DK76191A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rotary Switch, Piano Key Switch, And Lever Switch (AREA)
  • Insulated Conductors (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK076191A 1988-10-27 1991-04-25 Filamentoest haemagglutinin fra b.pertussis DK76191A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26364888A 1988-10-27 1988-10-27
PCT/US1989/004732 WO1990004641A1 (en) 1988-10-27 1989-10-20 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS)

Publications (2)

Publication Number Publication Date
DK76191D0 true DK76191D0 (da) 1991-04-25
DK76191A DK76191A (da) 1991-06-14

Family

ID=23002666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK076191A DK76191A (da) 1988-10-27 1991-04-25 Filamentoest haemagglutinin fra b.pertussis

Country Status (9)

Country Link
EP (1) EP0439542B1 (da)
JP (1) JPH04501506A (da)
AT (1) ATE176913T1 (da)
AU (1) AU643190B2 (da)
CA (1) CA1341123C (da)
DE (1) DE68928933T2 (da)
DK (1) DK76191A (da)
FI (1) FI911973A0 (da)
WO (1) WO1990004641A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643753A (en) 1990-04-18 1997-07-01 Connaught Laboratories Limited Use of autologous promoters to express gene products in bordetella
GB9008746D0 (en) * 1990-04-18 1990-06-13 Connaught Lab The use of autologous promoters to express gene products in bordetella
DE4111531A1 (de) * 1991-04-09 1992-10-29 Biotechnolog Forschung Gmbh Plasmide zur fha-expression und wirte
WO1994021816A1 (en) * 1993-03-25 1994-09-29 Envirocon International Incorporated Test kits and methods for rapidly testing for contamination by microorganisms
US5646251A (en) * 1993-11-05 1997-07-08 The Board Of Trustees Of Leeland Stanford Jr. Univ. Alloreaction-associated antigen (ARAG): a novel member of the immunoglobulin gene superfamily
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
EP1069133A1 (en) * 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis compounds and anti-infection applications thereof
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
EP2863943B1 (en) 2013-03-08 2016-07-13 Crucell Holland B.V. Acellular pertussis vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine

Also Published As

Publication number Publication date
DE68928933T2 (de) 1999-08-26
EP0439542A1 (en) 1991-08-07
CA1341123C (en) 2000-10-17
FI911973A7 (fi) 1991-04-23
EP0439542B1 (en) 1999-02-24
FI911973A0 (fi) 1991-04-23
JPH04501506A (ja) 1992-03-19
DK76191A (da) 1991-06-14
ATE176913T1 (de) 1999-03-15
AU4515589A (en) 1990-05-14
WO1990004641A1 (en) 1990-05-03
AU643190B2 (en) 1993-11-11
EP0439542A4 (en) 1991-11-06
DE68928933D1 (de) 1999-04-01

Similar Documents

Publication Publication Date Title
ES8801318A1 (es) Un procedimiento para la produccion de un peptido.
IT8419729A0 (it) Procedimento per la preparazione di vaccini polivalenti adsorbiti liofilizzati.
ATE229978T1 (de) Helicobacter proteine und impstoffe
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
FI953608L (fi) Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalvossa järjestelmällisellä rokottamisella
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
IT8720032A0 (it) Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DK76191D0 (da) Filamentoest haemagglutinin fra b.pertussis
ATE11547T1 (de) Neue d-homosteroide, ihre verwendung und herstellung, sowie pharmazeutische praeparate damit.
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
DE3854591D1 (de) Impfstoffe, deren charakteristischer Epitop in einem Picornavirusprotein, insbesondere Poliovirus, inkorporiert ist.
ATE422900T1 (de) Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält
IT8521718A0 (it) Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
HU9200583D0 (en) Method for producing el peptides of rubeola
GB9810084D0 (en) Proteins
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis
NO911673L (no) Filament - hemagglutinin av b. pertussis.
DK0809653T3 (da) Helicobacter pylori-antigen
AR012896A1 (es) Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori
NO912823D0 (no) Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette.